A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-ARM, MULTI-CENTER STUDY MEASURING THE EFFICACY AND SAFETY OF PRC-063 IN ADULT ADHD PATIENTS

Administered By

Psychiatry & Behavioral Sciences

Awarded By

Purdue Pharma L.P.

Contributors

Dew, Rachel E Physician
Kollins, Scott Haden Principal Investigator

Start/End

June 1, 2014 - May 31, 2015